BioStock: DanCann Pharma starts production of medical cannabis

Danish pharmaceutical company DanCann Pharma’s first factory for the development and manufacturing of cannabinoids for a wide range of diseases has now been commissioned. CEO and founder Jeppe Krog Rasmussen tells us more about this milestone and the plans ahead. We also learn the reason why he has strengthened his ownership further in the company, as well as the reason why an option program has been issued for the executive management team. 

Read the full interview with Jeppe Krog Rasmussen at biostock.se:

https://www.biostock.se/en/dancann-pharma-starts-production-of-medical-cannabis/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/